See also this year's filing and all EDGAR filings for this company.
PDF Report 0001694665_2023_Evelo_Biosciences_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001694665, Evelo Biosciences Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 51,573,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 4,842,000 |
3 | remainder_Assets | 8,026,000 |
4 | LiabilitiesCurrent | 12,395,000 |
5 | LiabilitiesNoncurrent | 57,038,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 29,912,000 |
9 | ResearchAndDevelopmentExpense | 78,554,000 |
10 | remainder_Expenses | 930,000 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -5,131,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 64,441,000 |
1 | Liabilities | 69,433,000 |
2 | Expenses | 109,396,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | -4,992,000 |
5 | NetIncome | -114,527,000 |
6 | ComprehensiveNetIncome | -114,527,000 |
7 | BaseVar | 124,200,500 |
8 | EconomicCapitalRatio | -1.84 |